Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Brentuximab vedotin & Cutaneous T cell lymphoma, brentuximab vedotin is a regulatory‑approved option for CD30‑positive cutaneous T‑cell lymphoma (Primary cutaneous anaplastic large‑cell lymphoma (pcALCL) and CD30‑expressing forms of mycosis fungoides (MF)) in both the US and EU, typically in the relapsed or refractory setting after at least one prior systemic re…